Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

66 trials with published results (19%)

Research Maturity

190 completed trials (54% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.1%

18 terminated out of 350 trials

Success Rate

91.3%

+4.8% vs benchmark

Late-Stage Pipeline

9%

33 trials in Phase 3/4

Results Transparency

35%

66 of 190 completed with results

Key Signals

66 with results91% success18 terminated

Data Visualizations

Phase Distribution

246Total
Not Applicable (168)
Early P 1 (4)
P 1 (20)
P 2 (21)
P 3 (17)
P 4 (16)

Trial Status

Completed190
Unknown58
Recruiting48
Terminated18
Withdrawn15
Active Not Recruiting14

Trial Success Rate

91.3%

Benchmark: 86.5%

Based on 190 completed trials

Clinical Trials (350)

Showing 20 of 20 trials
NCT02425345Not ApplicableCompleted

Women's Health Initiative Strong and Healthy Study

NCT06657976Phase 2RecruitingPrimary

Response to Exercise and Nitric Oxide in PAD

NCT07283289RecruitingPrimary

Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

NCT04007055Phase 3TerminatedPrimary

The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

NCT07655206Not ApplicableRecruitingPrimary

Home-based Exercise Therapy in Patients With Moderate to Severe Peripheral Artery Disease

NCT06319339Early Phase 1RecruitingPrimary

Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease

NCT06300450Not ApplicableRecruitingPrimary

Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy

NCT06318767Not ApplicableRecruiting

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

NCT05916950Not ApplicableRecruitingPrimary

The THOR IDE Study

NCT03871075Not ApplicableActive Not RecruitingPrimary

Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease

NCT06165016Not ApplicableActive Not RecruitingPrimary

Far Red Light to Improve Functioning in PAD

NCT04377126Phase 2CompletedPrimary

Unacylated Ghrelin to Improve Functioning in PAD

NCT05712395Not ApplicableRecruiting

The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease

NCT06890208Completed

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

NCT04794530Phase 3RecruitingPrimary

The COCOA-PAD II Trial

NCT07374601RecruitingPrimary

The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease

NCT07575568Not ApplicableNot Yet RecruitingPrimary

Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen

NCT04228978Not ApplicableRecruitingPrimary

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

NCT06033924Not ApplicableRecruitingPrimary

Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease

NCT05007925Not ApplicableCompletedPrimary

Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

Scroll to load more

Research Network

Activity Timeline